Marie Süße

Dr. Marie Süße


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 November 2021 in Cells
Verified
Journal Article
Open access
PDF file
FKFranz Felix Konen
Franz Felix Konen
PSPhilipp Schwenkenbecher
Philipp Schwenkenbecher
KJKonstantin Fritz Jendretzky
Konstantin Fritz Jendretzky
SGStefan Gingele
Stefan Gingele
KSKurt-Wolfram Sühs
Kurt-Wolfram Sühs
Thomas SkripuletzThomas Skripuletz
Thomas Skripuletz
Free light chains (FLC) are a promising biomarker to detect intrathecal inflammation in patients with inflammatory central nervous system (CNS) diseases, including multiple sclerosis (MS). The diagnostic use of this biomarker, in particular the kappa isoform of FLC (“KFLC”), has been investigated for more than 40 years. Based on an extensive literature review, we found that an agreement on the correct method for evaluating KFLC concentrations has not yet been reached. KFLC indices with varying cut-off values and blood-CSF-barrier (QAlbumin) related non-linear formulas for KFLC interpretation have been investigated in several studies. All approaches revealed high diagnostic sensitivity and specificity compared with the oligoclonal bands, which are considered the gold standard for the detection of intrathecally synthesized immunoglobulins. Measurement of KFLC is fully automated, rater-independent, and has been shown to be stable against most pre-analytic influencing factors. In conclusion, the determination of KFLC represents a promising diagnostic approach to show intrathecal inflammation in neuroinflammatory diseases. Multicenter studies are needed to show the diagnostic sensitivity and specificity of KFLC in MS by using the latest McDonald criteria and appropriate, as well as standardized, cut-off values for KFLC concentrations, preferably considering non-linear formulas such as Reiber’s diagram.

23 April 2018 in European Journal of Neurology
Verified
Journal Article
Closed access
PDF file
MSMarie Süße
Marie Süße
MHM. Hannich
M. Hannich
APA. Petersmann
A. Petersmann
SZS. Zylla
S. Zylla
MPM. Pietzner
M. Pietzner
ADAlexander Dressel
Alexander Dressel

12 February 2025 in Autoimmunity Reviews
Verified
Journal Article
Open access
FKFranz Felix Konen
Franz Felix Konen
UWUlrich Wurster
Ulrich Wurster
PSPhilipp Schwenkenbecher
Philipp Schwenkenbecher
AGAndreas Gerritzen
Andreas Gerritzen
CGCatharina C. Gross
Catharina C. Gross
TSThomas Skripuletz
Thomas Skripuletz
The 2024-revised McDonald criteria for multiple sclerosis (MS) proposed to incorporate cerebrospinal fluid (CSF)-specific oligoclonal bands and kappa free light chains (KFLC) as diagnostic biomarkers. While the 2017-revised criteria highlighted CSF-specific oligoclonal bands to indicate intrathecal IgG synthesis, significantly enhancing early MS diagnosis, KFLC have emerged as additional marker. Now, the question rises of whether both biomarkers serve as competing or complementary tools in MS diagnostics. In this narrative review, we extensively searched the literature on oligoclonal bands and KFLC determination in CSF and serum across neurological disorders, with a focus on MS, using the PubMed database to demonstrate the complementarity of both biomarkers. Oligoclonal bands have long been a reliable marker of intrathecal IgG synthesis in MS, valued for their high diagnostic sensitivity, unique patient "fingerprints," clonality differentiation, semi-quantitative analysis, and pre-analytic robustness. However, they present challenges in standardization, labor-intensity, method variability, examiner dependency, and limited data on non-IgG immunoglobulins. Quantitative KFLC measurement provides rapid, examiner-independent, and cost-effective assessment across all immunoglobulin classes but might have lower specificity, lacked consensus on standardized interpretation in recent years, and is not yet supported by comprehensive prospective multinational studies on its prognostic role. Both oligoclonal bands and KFLC have unique strengths and limitations that complement each other, potentially serving as complementary markers for evaluating intrathecal Ig synthesis in MS diagnosis. Further evidence is needed to establish the value of KFLC in MS diagnosis, thus multicenter prospective studies are being conducted to compare the diagnostic utility of both markers.

15 December 2020 in Journal of Neurology
Verified
Journal Article
Open access
PDF file
FNFriederike Neuß
Friederike Neuß
FPFelix von Podewils
Felix von Podewils
ZWZhong Irene Wang
Zhong Irene Wang
MSMarie Süße
Marie Süße
UZUwe Klaus Zettl
Uwe Klaus Zettl
MGMatthias Grothe
Matthias Grothe
Background: Multiple sclerosis (MS) is accompanied by an increased risk of epileptic seizures, but data with a detailed description of the competing causes are lacking. Methods: We aimed to describe a cohort of patients with both MS and epileptic seizures in a retrospective, population-based study. Results: We included 59 out of 2285 MS patients who had at least one epileptic seizure. Out of them, 22 had seizures before the diagnosis of MS, whereas epileptic seizures occurred after MS diagnosis in 37 patients, resulting in a total prevalence of epileptic seizures in MS of 2.6%. Competing causes could be found in 50.8% (30/59) of all patients, with 40.9% (9/22) compared to 56.8% (21/37) of the MS patients with seizures before vs after MS diagnosis. The main alternative causes were traumatic brain injury and cerebral ischemia accounting for more than 30% of the patients, with no difference between the subgroups. 33.3% and 55.6% of MS patients with seizures before/after MS diagnosis had documented pathological EEG alterations. Conclusion: A remarkable percentage of MS patients with epileptic seizures do have alternative competing causes at the time of the first seizure. A detailed diagnostic setup including patient history, EEG and MRI is recommended in the evaluation and choice for the best treatment.

3 April 2022 in Brain Sciences
Verified
Journal Article
Open access
PDF file
FKFranz Felix Konen
Franz Felix Konen
PSPhilipp Schwenkenbecher
Philipp Schwenkenbecher
KJKonstantin Fritz Jendretzky
Konstantin Fritz Jendretzky
SGStefan Gingele
Stefan Gingele
TWTorsten Witte
Torsten Witte
Thomas SkripuletzThomas Skripuletz
Thomas Skripuletz
Background: Oligoclonal bands represent intrathecal immunoglobulin G (IgG) synthesis and play an important role in the diagnosis of multiple sclerosis (MS). Kappa free light chains (KFLC) are increasingly recognized as an additional biomarker for intrathecal Ig synthesis. However, there are limited data on KFLC in neurological diseases other than MS. Methods: This study, conducted at two centers, retrospectively enrolled 346 non-MS patients. A total of 182 patients were diagnosed with non-inflammatory and 84 with inflammatory neurological diseases other than MS. A further 80 patients were classified as symptomatic controls. Intrathecal KFLC production was determined using different approaches: KFLC index, Reiber’s diagram, Presslauer’s exponential curve, and Senel’s linear curve. Results: Matching results of oligoclonal bands and KFLC (Reiber’s diagram) were frequently observed (93%). The Reiber’s diagram for KFLC detected intrathecal KFLC synthesis in an additional 7% of the patient samples investigated (4% non-inflammatory; 3% inflammatory), which was not found by oligoclonal band detection. Conclusions: The determination of both biomarkers (KFLC and oligoclonal bands) is recommended for routine diagnosis and differentiation of non-inflammatory and inflammatory neurological diseases. Due to the high sensitivity and physiological considerations, the assessment of KFLC in the Reiber’s diagram should be preferred to other evaluation methods.

5 February 2019 in European Journal of Neurology
Verified
Journal Article
Closed access
PDF file
MSMarie Süße
Marie Süße
NSNeels Saathoff
Neels Saathoff
MHMalte Hannich
Malte Hannich
FPFelix von Podewils
Felix von Podewils